22 December 2022
Seraphine Group plc
("Seraphine" or the "Group")
Appointment of Broker
Seraphine, the international digitally-led maternity and nursing wear brand, is pleased to announce the appointment of finnCap Ltd ("finnCap") as the Company's sole Broker with effect from today.
Sharon Flood, Chairman of Seraphine said: "I am pleased to announce the appointment of finnCap as the Company's broker and have been very impressed with how quickly they have developed a detailed understanding of the business, its culture and its strategy. I would also like to place on record my thanks to Numis for all the support they have given us; it is greatly appreciated."
Enquiries
For further information, please contact:
Seraphine Group | via Buchanan |
David N Williams, CEO | |
Lee Williams, CFO | |
| |
finnCap Ltd | via Buchanan |
Matt Goode, George Dollemore (Corporate Finance) | |
Charlotte Sutcliffe (ECM) | |
| |
Buchanan Communications | +44 (0)20 7466 5000 / Seraphine@buchanan.uk.com |
Helen Tarbet | |
Simon Compton | |
Jack Devoy | |
Abigail Gilchrist | |
About Seraphine
Seraphine is an international digitally-led maternity and nursing wear brand with a diverse range of innovative maternity and nursing products serving an under-competed global market.
Seraphine was founded in 2002 with the vision of creating desirable clothes which women would want to wear even if they were not pregnant, and this ethos remains true to this day. The Group has over 18 years' experience designing and developing maternity and nursing wear for women from first trimester to post-partum and nursing products.
The Group has achieved global brand recognition through its rapidly growing digital platform, which in the year to 4 April 2021, contributed to approximately 89% of revenue. The Group currently exports products to customers in over 120 countries globally, with the Group's largest markets being Europe, North America and the UK.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.